The Rx-to-OTC switch of Claritin, Allegra, and Zyrtec: an unprecedented FDA response to petitioners and the protection of public health.

Spencer, Holly M

The Rx-to-OTC switch of Claritin, Allegra, and Zyrtec: an unprecedented FDA response to petitioners and the protection of public health. [electronic resource] - The American University law review Jun 2002 - 999-1050 p. digital

Publication Type: Journal Article

0003-1453


Anti-Allergic Agents
Cetirizine
Drug Approval
Drug Costs
Drug Labeling
Drug Prescriptions--economics
Gatekeeping--legislation & jurisprudence
Humans
Legislation, Drug
Loratadine
Nonprescription Drugs--economics
Public Health Practice
Terfenadine--analogs & derivatives
United States
United States Food and Drug Administration--legislation & jurisprudence